Article

IL-13 is a driver of COVID-19 severity

2020-06-20

Abstract excerpt

Immune dysregulation is characteristic of the more severe stages of SARS-CoV-2 infection. Understanding the mechanisms by which the immune system contributes to COVID-19 severity may open new avenues to treatment. Here we report that elevated interleukin-13 (IL-13) was associated with the need for mechanical ventilation in two independent patient cohorts. In addition, patients who acquired COVID-19 while prescribe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb5dc239-ff0c-511b-9c16-6ec3788628ba
DOI: 10.1101/2020.06.18.20134353

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

IL-13 is a driver of COVID-19 severityDOI 10.1101/2020.06.18.20134353Read

Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesisSemantic proximity Read

Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolutionSemantic proximity Read

Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomesSemantic proximity Read

Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomesSemantic proximity Read

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19Semantic proximity Read

Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patientsSemantic proximity Read

Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19Semantic proximity Read

A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingSemantic proximity Read

Cell type-specific immune dysregulation in severely ill COVID-19 patientsSemantic proximity Read

CXCL13/CXCR5 Chemokine Axis Promotes CXCR5 <sup>+</sup> CD19 <sup>+</sup> B-Cell and Follicular/Effector CXCR5 <sup>+</sup> CD4 <sup>+</sup> T-Cell Responses in the Lungs Associated with Protection from Severe and Fatal COVID-19 Following Infection with Pathogenic SARS-CoV-2 Delta VariantSemantic proximity Read

Defective type I interferon immunity is associated with increasing COVID-19 severitySemantic proximity Read

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patientsSemantic proximity Read